Michael F. Mahoney - Feb 12, 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 12, 2025
Transactions value $
-$700,832
Form type
4
Date filed
2/14/2025, 05:29 PM
Previous filing
Feb 13, 2025
Next filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +13.7K +0.85% $0.00 1.63M Feb 12, 2025 Direct F1
transaction BSX Common Stock Tax liability -$701K -6.63K -0.41% $105.77 1.63M Feb 12, 2025 Direct
holding BSX Common Stock 201K Feb 12, 2025 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -13.7K -25% $0.00 41.1K Feb 12, 2025 Common Stock 13.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.